[go: up one dir, main page]

AU6927298A - Aminopyridine derivatives for inflammatory and malignant diseases - Google Patents

Aminopyridine derivatives for inflammatory and malignant diseases

Info

Publication number
AU6927298A
AU6927298A AU69272/98A AU6927298A AU6927298A AU 6927298 A AU6927298 A AU 6927298A AU 69272/98 A AU69272/98 A AU 69272/98A AU 6927298 A AU6927298 A AU 6927298A AU 6927298 A AU6927298 A AU 6927298A
Authority
AU
Australia
Prior art keywords
inflammatory
malignant diseases
aminopyridine derivatives
aminopyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69272/98A
Other languages
English (en)
Inventor
Doreen Mary Ashworth
David Michael Evans
David Alan Kendrick
Graeme Semple
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Publication of AU6927298A publication Critical patent/AU6927298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU69272/98A 1997-04-04 1998-04-03 Aminopyridine derivatives for inflammatory and malignant diseases Abandoned AU6927298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9706922A GB2323841A (en) 1997-04-04 1997-04-04 Pyridine derivatives with anti-tumor and anti-inflammatory activity
GB9706922 1997-04-04
PCT/GB1998/000998 WO1998045267A1 (fr) 1997-04-04 1998-04-03 Derives d'aminopyridine pour maladies inflammatoires et affections malignes

Publications (1)

Publication Number Publication Date
AU6927298A true AU6927298A (en) 1998-10-30

Family

ID=10810332

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69272/98A Abandoned AU6927298A (en) 1997-04-04 1998-04-03 Aminopyridine derivatives for inflammatory and malignant diseases

Country Status (3)

Country Link
AU (1) AU6927298A (fr)
GB (1) GB2323841A (fr)
WO (1) WO1998045267A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
CA2479744A1 (fr) 2002-03-28 2003-10-09 Paul E. Finke 2,3-diphenyl-pyridines substituees
DE602005017033D1 (de) 2004-06-16 2009-11-19 Wyeth Corp Amino-5,5-diphenylimidazolon-derivate zur beta-sekretase-hemmung
MXPA06014792A (es) 2004-06-16 2007-02-16 Wyeth Corp Difenilimidazopirimidina y aminas imidazol como inhibidores de ??-secretasa.
CA2593515A1 (fr) 2005-01-14 2006-07-20 Wyeth Amino-imidazolones destines a l'inhibition de la .beta.-secretase
RU2007124935A (ru) 2005-02-01 2009-03-10 Вайет (Us) АМИНОПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ β-СЕКТРЕТАЗЫ
JP2008530103A (ja) 2005-02-14 2008-08-07 ワイス β−セクレターゼ阻害剤としてのアゾリルアシルグアニジン
MX2008000212A (es) 2005-06-30 2008-03-24 Wyeth Corp Compuestos amino-5-(6 miembros)heteroarilimidazolona y el uso de estos para la modulacion de la (-secretasa.
TW200738683A (en) 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
KR20080050430A (ko) 2005-09-26 2008-06-05 와이어쓰 베타-세크레타제 (bace) 억제제로서아미노-5-[4-(디플루오로메톡시)페닐]-5-페닐이미다졸론화합물
WO2007100536A1 (fr) 2006-02-24 2007-09-07 Wyeth COMPOSES DE DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] POUR L'INHIBITION DE LA β-SECRETASE
US7700606B2 (en) 2006-08-17 2010-04-20 Wyeth Llc Imidazole amines as inhibitors of β-secretase
AR065814A1 (es) 2007-03-23 2009-07-01 Wyeth Corp Derivados de 5-fenilimidazolona,inhibidores de beta-secretasa,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar trastornos asociados a niveles beta-amiloides elevados.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0703905A1 (fr) * 1993-06-18 1996-04-03 Merck & Co. Inc. Inhibiteurs de farnesyle-proteine transferase
SK158196A3 (en) * 1994-06-10 1997-07-09 Rhone Poulenc Rorer Sa Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same
EP0794789A4 (fr) * 1995-01-12 1999-05-26 Univ Pittsburgh Inhibiteurs des prenyle transferases
US5631280A (en) * 1995-03-29 1997-05-20 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase

Also Published As

Publication number Publication date
GB9706922D0 (en) 1997-05-21
WO1998045267A1 (fr) 1998-10-15
GB2323841A (en) 1998-10-07

Similar Documents

Publication Publication Date Title
AU6148898A (en) 2-substituted 7-haloindenes and methods for synthesizing
AU1151099A (en) Azaoxindole derivatives
AU1825899A (en) Dota-biotin derivatives
AU2891097A (en) Carboline derivatives
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU2844897A (en) Bicyclic-fused pyridines
AU1735497A (en) Sulfonylureidopyrazole derivatives
AU3264695A (en) Pyridine derivative
AU6927298A (en) Aminopyridine derivatives for inflammatory and malignant diseases
AU3486195A (en) Pyrimidinone derivatives
AU7813598A (en) Betulinol derivatives
AU6729498A (en) Thiazolimine derivatives
AU1174199A (en) Biphenylamidine derivatives
AU2042897A (en) Aminopyridine derivatives
AUPO863197A0 (en) Novel derivatives
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AU695845B2 (en) Pyridine derivative
AU1562199A (en) Amino-benzothiazole derivatives
AU6115798A (en) Saponarin derivatives
AU8869098A (en) Preparation of pyridine derivatives
AU2753195A (en) Pyridine derivative
AU1691399A (en) 5-arylpyrrole derivatives
AU1877497A (en) Quinoxaline derivatives useful in therapy
AU6927198A (en) 3-aminopyridine derivatives for treatment of inflammatory and malignant diseases